Cord Blood News Volume 11.28 | Dec 3 2020

    0
    98







    2020-12-03 | CBN 11.28


    Cord Blood News by STEMCELL Technologies
    Vol. 11.28 – 3 December, 2020
    TOP STORY

    Human
    Umbilical Cord Mesenchymal Stem Cells-Derived Exosomal MicroRNA-451a Represses Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Inhibiting ADAM10

    Expression of miR-451a and a disintegrin and metalloprotease 10 in HCC tissues and adjacent normal tissues was determined. The exosomes were extracted from hucMSCs and co-cultured with Hep3B and SMMC-7721 cell lines.
    [RNA Biology]

    Abstract

    Getting enough cord blood HSCs for transplantation isn't easy. But she's paving the way. Watch Suzan Imren's webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Comparison
    of Reversal of Rat Pulmonary Fibrosis of Nintedanib, Pirfenidone, and Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly

    A stable animal model was established via an intratracheal injection of 5 mg bleomycin (BLM). One single transplantation of 2.5 × 107 human umbilical cord MSCs or initiation of daily oral nintedanib/pirfenidone administration was performed on day 21 following BLM damage.
    [Stem Cell Research & Therapy]

    Full Article

    Safety
    and Feasibility of Umbilical Cord Mesenchymal Stem Cells in Patients with COVID-19 Pneumonia: A Pilot Study

    Researchers conducted a small sample, single arm, pilot trial. In addition to standard therapy, they performed four rounds of transplantation of umbilical cell‐MSCs in sixteen patients with severe and critically severe COVID‐19.
    [Cell Proliferation]

    Full Article

    Cord Blood Maternal Microchimerism following Unrelated Cord Blood Transplantation

    Scientists employed a technique of highly sensitive HLA-specific quantitative-PCR assays targeting polymorphisms unique to the cord blood (CB) mother to assay CB-maternal microchimerism (MMc) in patients post-CB transplantation. After additional exclusion criteria, CB-MMc was evaluated at multiple timepoints in 36 patients.
    [Bone Marrow Transplantation]

    Abstract

    Logistics
    of an Advanced Therapy Medicinal Product during COVID-19 Pandemic in Italy: Successful Delivery of Mesenchymal Stromal Cells in Dry Ice

    Researchers assessed effects of the transition from liquid nitrogen to dry ice on cell viability; apoptosis; phenotype; proliferation; immunomodulation; and clonogenesis; and validated dry ice-based transport of umbilical cord-MSCs to clinics.
    [Journal of Translational Medicine]

    Full Article

    Mechanism
    of Human Umbilical Cord Mesenchymal Stem Cells Derived-Extracellular Vesicle in Cerebral Ischemia-Reperfusion Injury

    After extraction and identification of human umbilical cord MSCs (HMCs)-derived extracellular vesicles, ischemia reperfusion rat models were established and treated with HMC-EVs to measure pathological damage, apoptosis and inflammation in brain tissues.
    [Neurochemical Research]

    Abstract

    Human
    Amniotic Membrane-Mesenchymal Stem Cells-Conditioned Medium Reduces Inflammatory Factors and Fibrosis in Ovalbumin-Induced Asthma in Mice

    Investigators examined the effects of human amniotic membrane MSCs‐conditioned medium on ovalbumin (OVA)‐induced asthma. 48 hours after the last challenge, serum and bronchoalveolar lavage fluid samples were collected and used for evaluation of inflammatory factors and cells, respectively.
    [Experimental Physiology]

    Abstract


    Request your free copy of the 'Bone Marrow Niches and HSC Fates' Wallchart
    REVIEWS

    Mesenchymal
    Stem Cells: Amazing Remedies for Bone and Cartilage Defects

    MSCs obtained from various sources have diverse capabilities of secreting many different cytokines, growth factors, and chemokines. It is believed that the salutary effects of MSCs from different sources are not alike in terms of repairing or reformation of injured skeletal tissues.
    [Stem Cell Research & Therapy]

    Full Article
    INDUSTRY AND POLICY NEWS

    Government of Canada and JDRF Canada Announce New Research Funding to Accelerate Stem Cell-Based Therapies for Type 1 Diabetes

    To mark the end of Diabetes Awareness Month, Sonia Sidhu, Member of Parliament for Brampton South, on behalf of the Honourable Patty Hajdu, Minister of Health, announced an investment of $6 million through the CIHR-JDRF Partnership to Defeat Diabetes for two Canadian research teams to accelerate the development of stem cell-based therapies for the treatment of type 1 diabetes.
    [Juvenile Diabetes Research Foundation]

    Press Release

    Amnion
    Foundation Provides Seed Grants to Wake Forest, UNC-CH Researchers

    Three academic scientists at two North Carolina universities are among the recipients of the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.
    [Amnion Foundation (WRAL TechWire)]

    Press Release

    FEATURED EVENT

    International
    Symposium: Stem Cells: From Basic Science to Clinical Translation

    October 27 – October 29, 2021
    Tokyo, Japan


    > See All Events

    JOB OPPORTUNITIES

    Senior Research Technologist – Bone Marrow

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Fellow – Damaged Tissue Restoration

    University of Illinois at Chicago College of Medicine – Chicago, Illinois, United States


    Scientist – Blood Cell Development and Disorders

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Research
    Fellow – Stem Cell Biology & Engineering

    New York Blood Center – New York, New York, United States

    Research Professional – Life Sciences

    Stanford University – Stanford, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Cord Blood News
    Archives Contact Us
    Cord Blood News Twitter